Sunpharma launches Favipiravir tablet Fluguard to treat mild to moderate COVID-19 infections at Rs 35 per pill
Favipiravir is an antiviral drug that was originally made to treat influenza in Japan under the brand name Avigan.
Indian regulators give Glenmark approval to manufacture, sell favipiravir for ‘restricted emergency use’ in treating COVID-19 patients
Glenmark Pharmaceuticals Ltd has received Indian regulatory approval to make and sell oral antiviral drug favipiravir for treating mild-to-moderate COVID-19 infections in the country
Glenmark begins Phase 3 trials of antiviral drug Favipiravir to check efficacy on COVID-19 patients in India
Clinical trials are estimated to be completed by July-August and over 10 government and private hospitals are enrolled for the study.
Glenmark to conduct trials for potential COVID-19 drug, first company in India to receive DCGI approval; shares jump 9%
Glenmark filed the product for clinical trials with the DCGI and has received approval for conducting the trial on mild to moderate patients, said the BSE filing.
Glenmark Pharmaceuticals gets USFDA's final nod for Deferasirox tablets; company shares trade higher
The tablet is used to treat high levels of iron in the body caused by multiple blood transfusions
Q2 results paint a bleak picture for market, Adani Ports and SEZ in stable waters; all this and more on Moneycontrol Pro
Adani Ports volumes rose sharply despite depressed market conditions in global trade, which has affected India’s trade too.
How should Reserve Bank manage the rupee, stock picks from tech analysts; all this and more on Moneycontrol Pro
As the economic slowdown depeens, different government officials are speaking in different voices
India pharma majors Dr Reddy's, Wockhardt, and others deny allegations of conspiracy to fix prices in US
The generic drug makers are named in an anti-trust lawsuit in the US on allegations of engaging in a conspiracy to fix prices
Shares of Glenmark Pharmaceuticals were trading 2.17 percent up at Rs 625.20 on BSE
Defending its stand, the Centre had argued that the FDC medicines are "new drugs" and thus, require licence from Drugs Controller General for sale and manufacture.
FIPB has cleared foreign invest in 11 entities, worth Rs 1,075.91 cr, referred proposals worth Rs 4,187 crore in firms - Glenmark and Aurobindo - to CCEA
Delhi High Court today set aside its single judge's order restraining Mumbai-based generic drug maker Glenmark Pharmaceuticals Ltd from making and selling its antibiotic medicine Linezolid.
India's $15 billion pharmaceutical industry, which has been hit by a spate of regulatory sanctions in the past year.
Glenmark Generics Inc, the US-based subsidiary of Glenmark Generics Ltd (GGL), has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (USFDA) for Acamprosate Calcium Delayed Release Tablets, Glenmark Pharma said in a statement.
As per the United States Food and Drug Administration (USFDA) web site, the approvals were given for generic Riluzole oral tablets in the strength of 50 mg.
The Delhi HC today sought response of Glenmark Pharmaceuticals on US drug major Merck Sharp and Dohme's appeal against the single judge bench order.
The court case is an attempt by the Big Pharma to pressure the government to not give marketing approval for generic versions of drugs that have been accorded patent in India.
The Delhi High Court today refused to grant interim relief on a patent row to US pharmaceuticals major Merck Sharp and Dohme (MSD) which sought a restraint on Indian firm Glenmark manufacturing and marketing anti-diabetes drugs.
The interim application of the multinational pharma major that Glenmark be restrained from manufacturing and selling the anti-diabetes medicines on the grounds that the salt used in the drugs were not of generic nature was denied by the court.<br /><br />